EMIG (The Ethical Medicines Industry Group) has published its latest Brexit Barometer survey results, showing its members' views and feelings around preparations for Brexit.
The results paint a stark comparison between now and the feelings and concerns that existed a year previously.
The survey, in which 80% of respondents are from businesses that employ 250 people or fewer, showed the following:
- One in three now believe we are heading towards a 'no-deal' scenario. This has doubled since the year before. Just 15% think there will be a deal with the EU that preserves the status quo, or that will reverse Brexit altogether.
- 52% have spent over £100,000 on Brexit preparations, with 23% having spent over half a million pounds.
- 25% have changed the route for importing medicines into the UK.
- Approximately half are running down their stockpiles that they had built up for March.
- Most people have found enough warehouse space to store medicines; only 5% say there is not enough.
EMIG is a multi-stakeholder network and trade industry association that represents the interests of the full span of life sciences companies in the UK. Its industry members range from new business start-ups focused on R&D, through to well-established companies delivering a wide range of essential medicines to patients. Its members supply 50% of branded medicines by volume to the NHS.
It is not surprising that pharma has spent a lot of money preparing for Brexit, nor that there has been a big increase in feelings of a 'no-deal' Brexit, given the failure to agree anything in the spring and change in government.